{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:50:15Z","timestamp":1780080615365,"version":"3.54.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T00:00:00Z","timestamp":1434412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","award":["Career Development Award"],"award-info":[{"award-number":["Career Development Award"]}],"id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"publisher","award":["Landon Cancer Immunology Innovator Award"],"award-info":[{"award-number":["Landon Cancer Immunology Innovator Award"]}],"id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Herbert Irving Comprehensive Cancer Center at Columbia University"},{"name":"Tisch Cancer Center at the Icahn School of Medicine at Mount Sinai"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00262-015-1726-0","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T06:47:10Z","timestamp":1434350830000},"page":"1193-1203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas"],"prefix":"10.1007","volume":"64","author":[{"given":"Ellen H.","family":"de Moll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Wieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha","family":"Gnjatic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Remark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian G.","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Moskalenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammie","family":"Ferringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Chipuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil A.","family":"Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam B.","family":"Birge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne M.","family":"Saenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,16]]},"reference":[{"key":"1726_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(195301)6:1<1::AID-CNCR2820060102>3.0.CO;2-C","volume":"6","author":"AC Allen","year":"1953","unstructured":"Allen AC, Spitz S (1953) Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer 6:1\u201345","journal-title":"Cancer"},{"key":"1726_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/CCO.0b013e32834fcb0d","volume":"24","author":"AM Eggermont","year":"2012","unstructured":"Eggermont AM, Spatz A, Lazar V, Robert C (2012) Is ulceration in cutaneous melanoma just a prognostic and predictive factor or is ulcerated melanoma a distinct biologic entity? Curr Opin Oncol 24:137\u2013140. doi: 10.1097\/CCO.0b013e32834fcb0d","journal-title":"Curr Opin Oncol"},{"key":"1726_CR3","doi-asserted-by":"crossref","unstructured":"McMasters KM, Edwards MJ, Ross MI et al (2010) Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma. Ann Surg. 252:460\u2013465; discussion 465\u2013466. doi: 10.1097\/SLA.0b013e3181f20bb1","DOI":"10.1097\/SLA.0b013e3181f20bb1"},{"key":"1726_CR4","doi-asserted-by":"crossref","unstructured":"Suciu S, Ives N, Eggermont AM, Kirkwood JM, Lorigan P, Markovic S, Garbe C, Wheatley K (2014) Predictive importance of ulceration on the efficacy of adjuvant interferon-a (IFN): AN individual patient data (IPD) meta-analysis of 15 randomized trials in more than 7,500 melanoma patients (pts). J Clin Oncol 32 (suppl; abstr 9067)","DOI":"10.1200\/jco.2014.32.15_suppl.9067"},{"key":"1726_CR5","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2011.41.3799","volume":"30","author":"AM Eggermont","year":"2012","unstructured":"Eggermont AM, Suciu S, Testori A et al (2012) Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. J Clin Oncol 30:3810\u20133818. doi: 10.1200\/JCO.2011.41.3799","journal-title":"J Clin Oncol"},{"key":"1726_CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/CCO.0b013e328337fe8f","volume":"22","author":"A Spatz","year":"2010","unstructured":"Spatz A, Batist G, Eggermont AM (2010) The biology behind prognostic factors of cutaneous melanoma. Curr Opin Oncol 22:163\u2013168. doi: 10.1097\/CCO.0b013e328337fe8f","journal-title":"Curr Opin Oncol"},{"key":"1726_CR7","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1002\/1097-0142(19800615)45:12<3012::AID-CNCR2820451223>3.0.CO;2-O","volume":"45","author":"CM Balch","year":"1980","unstructured":"Balch CM, Wilkerson JA, Murad TM, Soong SJ, Ingalls AL, Maddox WA (1980) The prognostic significance of ulceration of cutaneous melanoma. Cancer 45:3012\u20133017","journal-title":"Cancer"},{"key":"1726_CR8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12094-012-0790-6","volume":"14","author":"JA Aviles-Izquierdo","year":"2012","unstructured":"Aviles-Izquierdo JA, Lazaro-Ochaita P (2012) Histological ulceration as a prognostic factor in cutaneous melanoma: a study of 423 cases in Spain. Clin Transl Oncol 14:237\u2013240. doi: 10.1007\/s12094-012-0790-6","journal-title":"Clin Transl Oncol"},{"key":"1726_CR9","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1200\/JCO.2004.03.075","volume":"22","author":"TK Eigentler","year":"2004","unstructured":"Eigentler TK, Buettner PG, Leiter U, Garbe C, Central Malignant Melanoma Registry of the German Dermatological S (2004) Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry. J Clin Oncol. 22:4376\u20134383. doi: 10.1200\/JCO.2004.03.075","journal-title":"J Clin Oncol."},{"key":"1726_CR10","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Gershenwald JE et al (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622\u20133634","journal-title":"J Clin Oncol"},{"key":"1726_CR11","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1200\/JCO.2002.07.082","volume":"20","author":"M Kashani-Sabet","year":"2002","unstructured":"Kashani-Sabet M, Sagebiel RW, Ferreira CM, Nosrati M, Miller JR 3rd (2002) Tumor vascularity in the prognostic assessment of primary cutaneous melanoma. J Clin Oncol 20:1826\u20131831","journal-title":"J Clin Oncol"},{"key":"1726_CR12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/pcmr.12315","volume":"28","author":"R Jewell","year":"2015","unstructured":"Jewell R, Elliott F, Laye J et al (2015) The clinicopathological and gene expression patterns associated with ulceration of primary melanoma. Pigment Cell Melanoma Res 28:94\u2013104. doi: 10.1111\/pcmr.12315","journal-title":"Pigment Cell Melanoma Res"},{"key":"1726_CR13","doi-asserted-by":"crossref","unstructured":"Suciu S, Ives N, Eggermont AM, Kirkwood JM, Lorigan P, Markovic S, Garbe C, Wheatley K (2014) Predictive importance of ulceration on the efficacy of adjuvant interferon-a (IFN): an individual patient data (IPD) meta-analysis of 15 randomized trials in more than 7,500 melanoma patients (pts). J Clin Oncol 32 (suppl; abstr9067)","DOI":"10.1200\/jco.2014.32.15_suppl.9067"},{"key":"1726_CR14","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/01.pas.0000213262.61855.7d","volume":"30","author":"H Grande Sarpa","year":"2006","unstructured":"Grande Sarpa H, Reinke K, Shaikh L, Leong SP, Miller JR 3rd, Sagebiel RW, Kashani-Sabet M (2006) Prognostic significance of extent of ulceration in primary cutaneous melanoma. Am J Surg Pathol 30:1396\u20131400. doi: 10.1097\/01.pas.0000213262.61855.7d","journal-title":"Am J Surg Pathol"},{"key":"1726_CR15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/CMR.0000000000000015","volume":"23","author":"M Qian","year":"2013","unstructured":"Qian M, Ma MW, Fleming NH, Lackaye DJ, Hernando E, Osman I, Shao Y (2013) Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis. Melanoma Res 23:461\u2013467. doi: 10.1097\/cmr.0000000000000015","journal-title":"Melanoma Res"},{"key":"1726_CR16","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1200\/JCO.2013.55.0491","volume":"32","author":"S Adams","year":"2014","unstructured":"Adams S, Gray RJ, Demaria S et al (2014) Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol 32:2959\u20132966. doi: 10.1200\/JCO.2013.55.0491","journal-title":"J Clin Oncol"},{"key":"1726_CR17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1200\/JCO.2011.41.0902","volume":"31","author":"S Loi","year":"2013","unstructured":"Loi S, Sirtaine N, Piette F et al (2013) Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. J Clin Oncol 31:860\u2013867. doi: 10.1200\/JCO.2011.41.0902","journal-title":"J Clin Oncol"},{"key":"1726_CR18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi NA, Hellmann MD, Snyder A et al (2015) Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348:124\u2013128. doi: 10.1126\/science.aaa1348","journal-title":"Science"},{"key":"1726_CR19","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","volume":"371","author":"A Snyder","year":"2014","unstructured":"Snyder A, Makarov V, Merghoub T et al (2014) Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med 371:2189\u20132199. doi: 10.1056\/NEJMoa1406498","journal-title":"N Engl J Med"},{"key":"1726_CR20","unstructured":"Goldsmith LA, Fitzpatrick TB (2012) Fitzpatrick\u2019s dermatology in general medicine. McGraw-Hill Medical, New York. Access Medicine. Web. September 28, 2014"},{"key":"1726_CR21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3389\/fimmu.2013.00436","volume":"4","author":"A Gallois","year":"2013","unstructured":"Gallois A, Bhardwaj N (2013) Dendritic cell-targeted approaches to modulate immune dysfunction in the tumor microenvironment. Front Immunol 4:436. doi: 10.3389\/fimmu.2013.00436","journal-title":"Front Immunol"},{"key":"1726_CR22","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/cncr.24909","volume":"116","author":"M Kashani-Sabet","year":"2010","unstructured":"Kashani-Sabet M (2010) Tumor progression by immune evasion in melanoma. Cancer 116:1623\u20131625. doi: 10.1002\/cncr.24909","journal-title":"Cancer"},{"key":"1726_CR23","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ejca.2009.05.034","volume":"45","author":"M Mandala","year":"2009","unstructured":"Mandala M, Imberti GL, Piazzalunga D et al (2009) Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database. Eur J Cancer 45:2537\u20132545. doi: 10.1016\/j.ejca.2009.05.034","journal-title":"Eur J Cancer"},{"key":"1726_CR24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/000313481107700219","volume":"77","author":"AL Burton","year":"2011","unstructured":"Burton AL, Roach BA, Mays MP et al (2011) Prognostic significance of tumor infiltrating lymphocytes in melanoma. Am Surg 77:188\u2013192","journal-title":"Am Surg"},{"key":"1726_CR25","doi-asserted-by":"crossref","first-page":"20429","DOI":"10.1073\/pnas.0905139106","volume":"106","author":"D Bogunovic","year":"2009","unstructured":"Bogunovic D, O\u2019Neill DW, Belitskaya-Levy I et al (2009) Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc Natl Acad Sci USA 106:20429\u201320434. doi: 10.1073\/pnas.0905139106","journal-title":"Proc Natl Acad Sci USA"},{"key":"1726_CR26","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaad.2014.01.914","volume":"70","author":"S Harcharik","year":"2014","unstructured":"Harcharik S, Bernardo S, Moskalenko M et al (2014) Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma. J Am Acad Dermatol 70:1036\u20131044. doi: 10.1016\/j.jaad.2014.01.914","journal-title":"J Am Acad Dermatol"},{"key":"1726_CR27","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.4049\/jimmunol.164.7.3591","volume":"164","author":"JM Green","year":"2000","unstructured":"Green JM, Karpitskiy V, Kimzey SL, Shaw AS (2000) Coordinate regulation of T cell activation by CD2 and CD28. J Immunol. 164:3591\u20133595","journal-title":"J Immunol."},{"key":"1726_CR28","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1073\/pnas.112212699","volume":"99","author":"EV Tibaldi","year":"2002","unstructured":"Tibaldi EV, Salgia R, Reinherz EL (2002) CD2 molecules redistribute to the uropod during T cell scanning: implications for cellular activation and immune surveillance. Proc Natl Acad Sci USA 99:7582\u20137587. doi: 10.1073\/pnas.112212699","journal-title":"Proc Natl Acad Sci USA"},{"key":"1726_CR29","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood-2002-07-2206","volume":"102","author":"K Crawford","year":"2003","unstructured":"Crawford K, Stark A, Kitchens B et al (2003) CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation. Blood 102:1745\u20131752. doi: 10.1182\/blood-2002-07-2206","journal-title":"Blood"},{"key":"1726_CR30","first-page":"43","volume":"74","author":"MC Mihm Jr","year":"1996","unstructured":"Mihm MC Jr, Clemente CG, Cascinelli N (1996) Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab Invest 74:43\u201347","journal-title":"Lab Invest"},{"key":"1726_CR31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00401-011-0841-z","volume":"122","author":"D Capper","year":"2011","unstructured":"Capper D, Preusser M, Habel A et al (2011) Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol 122:11\u201319. doi: 10.1007\/s00401-011-0841-z","journal-title":"Acta Neuropathol"},{"key":"1726_CR32","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1200\/JCO.2011.37.8539","volume":"30","author":"F Azimi","year":"2012","unstructured":"Azimi F, Scolyer RA, Rumcheva P, Moncrieff M, Murali R, McCarthy SW, Saw RP, Thompson JF (2012) Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol 30:2678\u20132683. doi: 10.1200\/JCO.2011.37.8539","journal-title":"J Clin Oncol"},{"key":"1726_CR33","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/bjd.12351","volume":"169","author":"G Safaee Ardekani","year":"2013","unstructured":"Safaee Ardekani G, Jafarnejad SM, Khosravi S, Martinka M, Ho V, Li G (2013) Disease progression and patient survival are significantly influenced by BRAF protein expression in primary melanoma. Br J Dermatol 169:320\u2013328. doi: 10.1111\/bjd.12351","journal-title":"Br J Dermatol"},{"key":"1726_CR34","first-page":"3883","volume":"63","author":"J Dong","year":"2003","unstructured":"Dong J, Phelps RG, Qiao R, Yao S, Benard O, Ronai Z, Aaronson SA (2003) BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Res 63:3883\u20133885","journal-title":"Cancer Res"},{"key":"1726_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bmsp.12046","volume":"68","author":"P Rijn van","year":"2015","unstructured":"van Rijn P, Rijmen F (2015) On the explaining-away phenomenon in multivariate latent variable models. Br J Math Stat Psychol 68:1\u201322. doi: 10.1111\/bmsp.12046","journal-title":"Br J Math Stat Psychol"},{"key":"1726_CR36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.jid.5701046","volume":"128","author":"G Panfilis De","year":"2008","unstructured":"De Panfilis G, Campanini N, Santini M et al (2008) Phase- and stage-related proportions of T cells bearing the transcription factor FOXP3 infiltrate primary melanoma. J Invest Dermatol. 128:676\u2013684. doi: 10.1038\/sj.jid.5701046","journal-title":"J Invest Dermatol."},{"key":"1726_CR37","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ et al (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199\u20136206. doi: 10.1200\/JCO.2009.23.4799","journal-title":"J Clin Oncol"},{"key":"1726_CR38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1755-148X.2008.00451.x","volume":"21","author":"L Fried","year":"2008","unstructured":"Fried L, Arbiser JL (2008) The reactive oxygen-driven tumor: relevance to melanoma. Pigment Cell Melanoma Res 21:117\u2013122. doi: 10.1111\/j.1755-148X.2008.00451.x","journal-title":"Pigment Cell Melanoma Res"},{"key":"1726_CR39","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","volume":"30","author":"F Colotta","year":"2009","unstructured":"Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30:1073\u20131081. doi: 10.1093\/carcin\/bgp127","journal-title":"Carcinogenesis"},{"key":"1726_CR40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejca.2011.09.028","volume":"48","author":"AM Eggermont","year":"2012","unstructured":"Eggermont AM, Suciu S, Testori A et al (2012) Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. Eur J Cancer 48:218\u2013225. doi: 10.1016\/j.ejca.2011.09.028","journal-title":"Eur J Cancer"},{"key":"1726_CR41","first-page":"3022","volume":"27","author":"J Baurain","year":"2009","unstructured":"Baurain J, Stas M, Hammouch F et al (2009) Association of primary melanoma ulceration and clinical benefit of adjuvant vaccination with tumor-specific antigenic peptides. ASCO Meet Abstr 27:3022","journal-title":"ASCO Meet Abstr"},{"key":"1726_CR42","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2013.50.1114","volume":"31","author":"D Han","year":"2013","unstructured":"Han D, Zager JS, Shyr Y et al (2013) Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. J Clin Oncol 31:4387\u20134393. doi: 10.1200\/JCO.2013.50.1114","journal-title":"J Clin Oncol"},{"key":"1726_CR43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.immuni.2013.07.008","volume":"39","author":"J Galon","year":"2013","unstructured":"Galon J, Angell HK, Bedognetti D, Marincola FM (2013) The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity 39:11\u201326. doi: 10.1016\/j.immuni.2013.07.008","journal-title":"Immunity"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1726-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-015-1726-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1726-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T04:34:42Z","timestamp":1652416482000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-015-1726-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,16]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1726"],"URL":"https:\/\/doi.org\/10.1007\/s00262-015-1726-0","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,16]]}}}